Analysis of 105 NPC samples indicated that TBL1XR1 expression was correlated with clinical staging (P = 0.001), T classification (P = 0.040), N classification (P = 0.003), and patient survival (P = 0.001). The gene discussed is TBL1XR1; the disease is nasopharyngeal carcinoma.